Research for Drug Development and Discovery Capabilities
Our core expertise lies at the intersection of biologics and gene therapy, enabling us to proficiently administer intricate dose routes and provide a comprehensive support infrastructure for the evaluation of critical endpoints and biomarkers. Our particular emphasis rests on toxicity and immunology assessments, ensuring a thorough understanding of the impact of novel therapies. While our primary focus is early-stage discovery encompassing PK/PD and toxicity investigations, we have also cultivated well-defined pharmacology models in diverse domains, including metabolic and respiratory diseases.
Pharmacokinetics
With our expertise in drug absorption, distribution, metabolism, and excretion, we provide valuable insights that guide dosing strategies, ensuring the safe and efficient delivery of medications to target sites within the body.
Our in-depth understanding of drug-body interactions allows us to precisely tailor treatments, ensuring they have the desired therapeutic effects. This knowledge is instrumental in optimizing drug regimens for maximum efficacy.
Toxicology
Our meticulous toxicology assessments not only meet stringent regulatory standards but also offer a comprehensive understanding of the potential risks associated with substances. This commitment to safety is paramount in the development of pharmaceuticals and biologics.
Talk to an Expert About Our Capabilities
Feel free to reach out to our team of experts if you have any questions or require more information about our research and services. We're here for the journey towards innovation, and providing you with the guidance and insights you need.
